Akoya Biosciences Valuation
| AKYA Stock | USD 2.12 0.01 0.47% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Akoya Biosciences shows a prevailing Real Value of $4.94 per share. The current price of the firm is $2.12. Our model approximates the value of Akoya Biosciences from analyzing the firm fundamentals such as Return On Equity of -1.28, profit margin of (0.65) %, and Current Valuation of 153.6 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Akoya Biosciences' valuation include:
Price Book 7.671 | Enterprise Value 153.6 M | Enterprise Value Ebitda (6.83) | Price Sales 1.1219 | Enterprise Value Revenue 1.7693 |
Undervalued
Today
Please note that Akoya Biosciences' price fluctuation is unstable at this time. Calculation of the real value of Akoya Biosciences is based on 3 months time horizon. Increasing Akoya Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Akoya Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akoya Stock. However, Akoya Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.12 | Real 4.94 | Target 13.13 | Hype 2.12 | Naive 1.65 |
The real value of Akoya Stock, also known as its intrinsic value, is the underlying worth of Akoya Biosciences Company, which is reflected in its stock price. It is based on Akoya Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Akoya Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Akoya Biosciences helps investors to forecast how Akoya stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akoya Biosciences more accurately as focusing exclusively on Akoya Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Akoya Biosciences' intrinsic value based on its ongoing forecasts of Akoya Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Akoya Biosciences' closest peers. If more than one evaluation category is relevant for Akoya Biosciences we suggest using both methods to arrive at a better estimate.
Akoya Biosciences Cash |
|
Akoya Valuation Trend
Comparing Akoya Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Akoya Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Akoya Revenue by Product
Akoya Biosciences Total Value Analysis
Akoya Biosciences is presently anticipated to have valuation of 153.6 M with market capitalization of 104.58 M, debt of 85.71 M, and cash on hands of 87.61 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Akoya Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
153.6 M | 104.58 M | 85.71 M | 87.61 M |
Akoya Biosciences Investor Information
About 70.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.16. Akoya Biosciences had not issued any dividends in recent years. Based on the key indicators related to Akoya Biosciences' liquidity, profitability, solvency, and operating efficiency, Akoya Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Akoya Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Akoya Biosciences has an asset utilization ratio of 53.58 percent. This suggests that the Company is making $0.54 for each dollar of assets. An increasing asset utilization means that Akoya Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Akoya Biosciences Ownership Allocation
Akoya Biosciences holds a total of 49.56 Million outstanding shares. The majority of Akoya Biosciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Akoya Biosciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Akoya Biosciences. Please pay attention to any change in the institutional holdings of Akoya Biosciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Akoya Biosciences Profitability Analysis
The company reported the previous year's revenue of 96.63 M. Net Loss for the year was (63.32 M) with profit before overhead, payroll, taxes, and interest of 43.39 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Akoya Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Akoya Biosciences and how it compares across the competition.
About Akoya Biosciences Valuation
The stock valuation mechanism determines Akoya Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Akoya Biosciences. We calculate exposure to Akoya Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Akoya Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 56.3 M | 40.6 M | |
| Pretax Profit Margin | (0.65) | (0.69) | |
| Operating Profit Margin | (0.60) | (0.63) | |
| Net Loss | (0.66) | (0.69) | |
| Gross Profit Margin | 0.58 | 0.66 |
Akoya Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 44.4 M |
Akoya Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Akoya Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Akoya we look at many different elements of the entity such as Akoya's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Akoya Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Akoya Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Akoya Biosciences' worth.Complementary Tools for Akoya Stock analysis
When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |